Off-label use of medication may be presented in these guidelines if a sufficient level of
evidence shows that it can be considered medically appropriate to a given condition and if …

Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …

ESC Guidelines e341 (1) the specific situation of the patient. In this respect, it is specified
that, unless otherwise provided for by national regulations, offlabel use of medication should …

Cancer-associated thrombosis (including venous thromboembolism (VTE) and arterial
events) is highly consequential for patients with cancer and is associated with worsened …

Importance Pulmonary embolism (PE) is characterized by occlusion of blood flow in a
pulmonary artery, typically due to a thrombus that travels from a vein in a lower limb. The …

In response to the COVID-19 pandemic, vaccines for SARS-CoV-2 were developed, tested,
and introduced at a remarkable speed. Although the vaccine introduction had a major …

The prevention and management of bleeding and thrombosis in patients with cirrhosis
poses several difficult clinical questions. These Clinical Practice Guidelines have been …

Patients diagnosed with coronavirus disease 2019 (COVID-19) associated with severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection frequently experience …

Aims To systematically assess late outcomes of acute pulmonary embolism (PE) and to
investigate the clinical implications of post-PE impairment (PPEI) fulfilling prospectively …

Background Due to the bleeding risk of full-dose systemic thrombolysis and the lack of major
trials focusing on the clinical benefits of catheter-directed treatment, heparin …